Genmab A/S - American Depositary Shares — Informes financieros (NASDAQ:GMAB)

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

GMAB

Financials

Genmab A/S - American Depositary Shares

Noticias

Genmab: Multiple Binaries Could Alter The Thesis (NASDAQ:GMAB)

JNJ: Success In Multiple Myeloma Underpins $25B In Growth By 2030 (NYSE:JNJ)

Wolfe Research inicia cobertura de Genmab con calificación de superar al mercado

Genmab nombra liderazgo y otorga incentivos en acciones

Biopharma europea sigue siendo apuesta defensiva por crecimiento estable y caja: Bernstein

Las bolsas de valores de Dinamarca cerraron con subidas; el OMX Copenhagen 20 ganó un 0.00%

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.00%

Harbor Health Care ETF Q4 2025 Portfolio Review

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.20%

Las bolsas de valores de Dinamarca cerraron con subidas; el OMX Copenhagen 20 ganó un 0.20%

Las bolsas de valores de Dinamarca cerraron con caídas; el OMX Copenhagen 20 perdió un 1.23%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.23%